273 related articles for article (PubMed ID: 31399962)
1. Polycystic Kidney Disease and Renal Fibrosis.
Xue C; Mei CL
Adv Exp Med Biol; 2019; 1165():81-100. PubMed ID: 31399962
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Fibrosis in Polycystic Kidney Disease.
Song CJ; Zimmerman KA; Henke SJ; Yoder BK
Results Probl Cell Differ; 2017; 60():323-344. PubMed ID: 28409351
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.
Zhang Y; Reif G; Wallace DP
Cell Signal; 2020 Aug; 72():109646. PubMed ID: 32311505
[TBL] [Abstract][Full Text] [Related]
4. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.
Raman A; Parnell SC; Zhang Y; Reif GA; Dai Y; Khanna A; Daniel E; White C; Vivian JL; Wallace DP
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1695-F1707. PubMed ID: 30332313
[TBL] [Abstract][Full Text] [Related]
5. CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease.
Zhou JX; Cheng AS; Chen L; Li LX; Agborbesong E; Torres VE; Harris PC; Li X
Cells; 2024 Mar; 13(6):. PubMed ID: 38534333
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
[TBL] [Abstract][Full Text] [Related]
7. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
8. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
[TBL] [Abstract][Full Text] [Related]
9. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
Ding H; Li LX; Harris PC; Yang J; Li X
Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).
Norman J
Biochim Biophys Acta; 2011 Oct; 1812(10):1327-36. PubMed ID: 21745567
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
13. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
[TBL] [Abstract][Full Text] [Related]
14. Polycystic kidney disease: etiology, pathogenesis, and treatment.
Martinez JR; Grantham JJ
Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
[TBL] [Abstract][Full Text] [Related]
15. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
[TBL] [Abstract][Full Text] [Related]
16. Periostin in the Kidney.
Wallace DP
Adv Exp Med Biol; 2019; 1132():99-112. PubMed ID: 31037629
[TBL] [Abstract][Full Text] [Related]
17. The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.
Fragiadaki M; Macleod FM; Ong ACM
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255651
[TBL] [Abstract][Full Text] [Related]
18. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.
Su Z; Wang X; Gao X; Liu Y; Pan C; Hu H; Beyer RP; Shi M; Zhou J; Zhang J; Serra AL; Wüthrich RP; Mei C
J Intern Med; 2014 Nov; 276(5):470-85. PubMed ID: 24494798
[TBL] [Abstract][Full Text] [Related]
19. Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease.
Wallace DP; White C; Savinkova L; Nivens E; Reif GA; Pinto CS; Raman A; Parnell SC; Conway SJ; Fields TA
Kidney Int; 2014 Apr; 85(4):845-54. PubMed ID: 24284511
[TBL] [Abstract][Full Text] [Related]
20. Macrophages promote polycystic kidney disease progression.
Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
